Following the US approval on January 6 beneath the business title Leqembi, Tokyo-headquartered Eisai (which takes the lead on the collaboration with Biogen...
STOCKHOLM, Jan. 16, 2023 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) associate Eisai introduced immediately that Eisai has submitted a advertising...
STOCKHOLM, Jan. 16, 2023 /PRNewswire/ -- BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) accomplice Eisai introduced at present that Eisai has submitted a...
TOKYO and CAMBRIDGE, Mass., Jan. 15, 2023 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB,...
The FDA has discouraged the pursuit of a advertising authorization of the PI3K inhibitor zandelisib in sufferers with follicular lymphoma or marginal zone...
The Federal Communications Fee (FCC) brand is seen earlier than the FCC Internet Neutrality listening to in Washington February 26, 2015. REUTERS/Yuri GripasRegister...
